Skip to main content
. 2007 Dec 26;82(6):2705–2714. doi: 10.1128/JVI.02461-07

TABLE 4.

p53 sequence analysis for cancerous prostate specimens

Specimen Localizationa of:
p53 sequenceb
TAg p53 Exon Entire thin section LCM cellsc
C1 Cyto Cyto 5-6 wt, mt (Thr 140 to Ile) wt
9 wt ND
C2 Cyto Cyto 5-6 wt wt
7-8 wt wt
9 wt wt
C3 Cyto Cyto 5-6 wt wt
7-8 wt wt*
9 wt wt
C4 Cyto Cyto 5-6 mt (Pro 191 to Leu) wt
7-8 wt wt
9 wt wt
C5 Cyto Cyto 5-6 ND wt
7-8 wt wt*
9 wt wt
C6 Nuc 5-6 wt wt
7-8 wt wt
9 wt wt, mt (Pro 318 to Ser)
C7 Nuc 5-6 wt wt
7-8 wt wt*
9 wt wt
C8 Nuc 5-6 wt wt
7-8 wt wt*
9 ND wt
a

Nuc, nuclear; Cyto, cytoplasmic.

b

wt, wild type; mt, mutant; ND, not determined.

c

LCM was performed on TAg+ PIA cells (specimens C1 to C5) and on Tag tumor cells (specimens C6 to C8). Asterisks indicate specimens for which the exon 8 sequence could be amplified but good-quality sequence could not be obtained.